SCHEMBL20667980

SCHEMBL20667980

CCCCNc1nc(C)nc2sc(C)c(C)c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.53
▸ LMNA P02545 5/20 0.53
▸ HTT P42858 4/20 0.53
▸ MEN1 O00255 1/20 0.51
▸ RAF1 P04049 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ ALDH1A1 P00352 7/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ MAPK1 P28482 3/20 0.50
▸ GAA P10253 2/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ CRHR1 P34998 1/20 0.47
▸ PRKCI P41743 3/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ MAPT P10636 3/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ PLA2G1B P04054 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ ATG4B Q9Y4P1 1/20 0.42
▸ TLR8 Q9NR97 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24305688 0.77 ALDH1A1 (0.42) SMN1; SMN2LMNAHTTMEN1RAF1
SCHEMBL20667975 0.76 HTT (0.69) SMN1; SMN2LMNAHTTALDH1A1KDM4E
SCHEMBL20667920 0.75 MAPT (0.62) SMN1; SMN2LMNAHTTMEN1KMT2A
SCHEMBL20668099 0.72 GAA (0.68) SMN1; SMN2LMNAHTTMEN1KMT2A
SCHEMBL20667974 0.72 KDM4E (0.51) SMN1; SMN2LMNAALDH1A1KDM4ECRHR1
SCHEMBL20659861 0.67 MAPT (0.65) SMN1; SMN2LMNAHTTRAF1ALDH1A1
SCHEMBL22448323 0.66 CYP3A4 (0.41) KDM4ECRHR1CYP3A4NPSR1TLR8
SCHEMBL9125039 0.64 TLR8 (0.53) CRHR1CYP3A4TLR8TLR7
SCHEMBL9125885 0.64 TLR8 (0.49) CYP3A4TLR8TLR7
SCHEMBL7774641 0.63 SLC29A1 (0.50) SMN1; SMN2LMNAHTTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220117968-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS SAINT LOUIS UNIVERSITY 2022-04-21 — — US disclosed
WO-2019018359-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS SAINT LOUIS UNIVERSITY (US) 2019-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220117968-A1 THIENO[2,3-D)PYRIMIDINES AND BENZOFURO(3,2-D)PYRIMIDINES AS ANTIMICROBIAL AGENTS TYMS, DPYD, UMPS SMN1; SMN2 3418/4885LMNA 3741/4885HTT 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback